Norway Savings Bank Purchases 765 Shares of Becton, Dickinson and Company (NYSE:BDX)

Norway Savings Bank boosted its position in Becton, Dickinson and Company (NYSE:BDXFree Report) by 72.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,825 shares of the medical instruments supplier’s stock after purchasing an additional 765 shares during the quarter. Norway Savings Bank’s holdings in Becton, Dickinson and Company were worth $445,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in Becton, Dickinson and Company by 2.0% during the third quarter. Vanguard Group Inc. now owns 25,927,519 shares of the medical instruments supplier’s stock valued at $6,703,041,000 after buying an additional 516,427 shares during the period. State Street Corp boosted its position in shares of Becton, Dickinson and Company by 0.6% during the 2nd quarter. State Street Corp now owns 12,762,618 shares of the medical instruments supplier’s stock valued at $3,369,459,000 after acquiring an additional 76,244 shares during the last quarter. Morgan Stanley boosted its position in shares of Becton, Dickinson and Company by 4.5% during the 3rd quarter. Morgan Stanley now owns 10,200,213 shares of the medical instruments supplier’s stock valued at $2,637,062,000 after acquiring an additional 435,168 shares during the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of Becton, Dickinson and Company by 11.0% during the third quarter. Massachusetts Financial Services Co. MA now owns 5,192,832 shares of the medical instruments supplier’s stock worth $1,342,503,000 after purchasing an additional 512,566 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Becton, Dickinson and Company by 2.3% in the second quarter. Geode Capital Management LLC now owns 5,134,645 shares of the medical instruments supplier’s stock worth $1,351,490,000 after purchasing an additional 113,425 shares during the last quarter. 86.72% of the stock is currently owned by hedge funds and other institutional investors.

Becton, Dickinson and Company Stock Performance

NYSE BDX opened at $246.25 on Friday. The company has a 50-day simple moving average of $238.71 and a two-hundred day simple moving average of $245.74. Becton, Dickinson and Company has a 12-month low of $229.85 and a 12-month high of $287.32. The firm has a market cap of $71.14 billion, a price-to-earnings ratio of 58.35, a PEG ratio of 2.00 and a beta of 0.42. The company has a quick ratio of 0.64, a current ratio of 1.08 and a debt-to-equity ratio of 0.56.

Becton, Dickinson and Company (NYSE:BDXGet Free Report) last released its earnings results on Thursday, February 1st. The medical instruments supplier reported $2.68 earnings per share for the quarter, beating analysts’ consensus estimates of $2.39 by $0.29. The company had revenue of $4.71 billion during the quarter, compared to analyst estimates of $4.73 billion. Becton, Dickinson and Company had a return on equity of 13.57% and a net margin of 6.44%. Becton, Dickinson and Company’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.98 EPS. On average, equities analysts forecast that Becton, Dickinson and Company will post 12.94 EPS for the current year.

Becton, Dickinson and Company Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, March 29th. Investors of record on Friday, March 8th will be paid a $0.95 dividend. This represents a $3.80 annualized dividend and a dividend yield of 1.54%. The ex-dividend date is Thursday, March 7th. Becton, Dickinson and Company’s payout ratio is 90.05%.

Insider Activity at Becton, Dickinson and Company

In other Becton, Dickinson and Company news, SVP Thomas J. Spoerel sold 282 shares of the firm’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $238.29, for a total value of $67,197.78. Following the sale, the senior vice president now owns 2,276 shares of the company’s stock, valued at approximately $542,348.04. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.31% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on BDX. Morgan Stanley dropped their target price on shares of Becton, Dickinson and Company from $310.00 to $280.00 and set an “overweight” rating for the company in a research report on Monday, December 4th. Barclays lifted their price objective on shares of Becton, Dickinson and Company from $301.00 to $305.00 and gave the stock an “overweight” rating in a report on Monday, February 5th. Finally, Raymond James increased their target price on Becton, Dickinson and Company from $269.00 to $275.00 and gave the company an “outperform” rating in a research note on Wednesday, January 3rd. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $279.17.

Read Our Latest Stock Report on Becton, Dickinson and Company

Becton, Dickinson and Company Profile

(Free Report)

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.

Further Reading

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDXFree Report).

Institutional Ownership by Quarter for Becton, Dickinson and Company (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.